ImpriMed
Mountain View, California, United States · Artificial Intelligence, Biotechnology, Health Care
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMed’s key product, Personalized Prediction Profile, has been used by board-certified veterinary oncologists, helping over 4,000 dogs with lymphoma and leukemia. With ImpriMed’s services, veterinarians make their treatment decisions quickly and with confidence. This innovative approach t
Key facts
- Headquarters
- Mountain View, California, United States
- Employees
- 46
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- www.imprimedicine.com
- Company page
Recent activity at ImpriMed
- : ImpriMed secures $10 million in a Series A2 bridge round, with NAVER D2SF as a key investor. This funding will help ImpriMed advance its AI-driven precision medicine solutions.
- : ImpriMed Appoints Valerie Goodwin-Adams as Chief Commercial Officer
- : Imprimed Raises $23 Million Series A Round To Expand Its Revolutionary Ai-Powered Cancer Treatment Technology
ImpriMed funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Series A | $10.0M |
| Dec 2023 | Series A | $23.0M |
Leadership
- Valerie Goodwin-Adams, Chief Commercial Officer
- Jamin Koo, Founder
- Sungwon Lim, Chief Executive Officer
Verified email and direct lines for ImpriMed’s decision-makers are on Fundz. See plans
ImpriMed in the news
Companies similar to ImpriMed
- Vektor Medical · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Medical
- AKASA · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Medical
- C the Signs · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Medical
- Caristo Diagnostics · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Medical
- TidalSense · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Medical
About ImpriMed: questions and answers
What does ImpriMed do?
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMed’s key product, Personalized Prediction Profile, has been used by board-certified veterinary oncologists, helping over 4,000 dogs with lymphoma and leukemia. With ImpriMed’s services, veterinarians make their treatment decisions quickly and with confidence. This innovative approach t
Where is ImpriMed headquartered?
ImpriMed is headquartered in Mountain View, California, United States.
How many employees does ImpriMed have?
ImpriMed has about 46 employees.
Has ImpriMed raised funding?
Yes. Fundz has recorded 2 funding events for ImpriMed. The most recent, Series A of $10.0M, was in Sep 2026.
Who leads ImpriMed?
Jamin Koo is a Founder at ImpriMed.
What is the latest news on ImpriMed?
On Sep 18, 2026, ImpriMed secures $10 million in a Series A2 bridge round, with NAVER D2SF as a key investor. This funding will help ImpriMed advance its AI-driven precision medicine solutions.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy